Conestoga discloses 5.06% Exponent Inc (NASDAQ: EXPO) ownership stake
Rhea-AI Filing Summary
Conestoga Capital Advisors filed Amendment No. 3 to a Schedule 13G reporting its beneficial ownership of 2,526,244 shares of Exponent Inc common stock, representing 5.06% of the outstanding class as of 12/31/2025. Conestoga has sole power to vote and dispose of 2,392,498 of these shares and no shared voting or dispositive power. The firm is classified as an investment adviser and certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Exponent Inc.
Positive
- None.
Negative
- None.
FAQ
What percentage of Exponent Inc (EXPO) does Conestoga Capital Advisors report owning?
Conestoga Capital Advisors reports beneficial ownership of 5.06% of Exponent Inc's common stock, based on 2,526,244 shares as disclosed in the Schedule 13G/A.
How many Exponent Inc (EXPO) shares does Conestoga Capital Advisors control the voting for?
Conestoga Capital Advisors has sole voting power over 2,392,498 Exponent Inc common shares and reports no shared voting power.
Does Conestoga Capital Advisors seek to influence control of Exponent Inc (EXPO)?
No. Conestoga Capital Advisors certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Exponent Inc.
What type of reporting person is Conestoga Capital Advisors in this Schedule 13G/A for EXPO?
Conestoga Capital Advisors is classified as an investment adviser (IA) under the applicable SEC rules in this Schedule 13G/A.
What is the event date for Conestoga Capital Advisors’ ownership report on Exponent Inc (EXPO)?
The date of the event requiring this ownership report is 12/31/2025, as stated in the Schedule 13G/A.
What is the CUSIP number and security class reported for Exponent Inc (EXPO)?
The filing covers Exponent Inc Common Stock with CUSIP 30214U102, as disclosed in the ownership sections.